Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

548
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
548
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.5K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.8K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

55
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

48
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ONYCHOLYSIS AS A COMPLICATION OF TAXANE-BASED CHEMOTHERAPY WITH CONCOMITANT CRYOTHERAPY IN BREAST CANCER PATIENTS: TWO CASE REPORTS.

Georgian medical news·2024
Same author

THE EFFECT OF HIGH INTENSITY WHITE NOISE ON THE ULTRASTRUCTURE OF AXO-DENDRITIC SYNAPSES IN COLLICULUS INFERIOR OF ADULT MALE CATS. QUANTITATIVE ELECTRON MICROSCOPIC STUDY.

Georgian medical news·2021
Same author

[MENTAL AND SPEECH DEVELOPMENT IN CHILDREN LIVING IN ECOLOGICALLY UNFAVOURABLE REGIONS OF GEORGIA].

Georgian medical news·2021
Same author

FINE ARCHITECTURE OF THE HIPPOCAMPUS IN ADOLESCENT, ADULT AND AGED RATS. ELECTRON MICROSCOPIC STUDY.

Georgian medical news·2021
Same author

[NEUROLOGICAL DISORDERS OF CHILDREN LIVING IN ECOLOGICALLY AFFECTED REGION OF GEORGIA].

Georgian medical news·2021
Same author

[MODERN ISSUES OF KALCIPHEROL INFLUENCE ON CHILDREN AND ADULTS' HEALTH (REVIEW)].

Georgian medical news·2021

Related Experiment Video

Updated: Nov 2, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

648

COVID-19 AND CHILDREN: COMPLICATIONS AND LATE OUTCOMES.

M Zhvania1, M Kvezereli-Kopadze1, T Kutubidze1

  • 1Tbilisi State Medical University, G. Zhvania Pediatric Academic Clinic, Georgia.

Georgian Medical News
|June 9, 2021
PubMed
Summary

Even asymptomatic COVID-19 in children can lead to late complications, including multisystem inflammatory syndrome (MIS-C). Pediatricians must monitor children post-infection for these potential long-term health issues.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K

Related Experiment Videos

Last Updated: Nov 2, 2025

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

648
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.5K

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • COVID-19 presents a global health challenge, particularly for pediatric populations.
  • While often mild or subclinical in children, COVID-19 can result in severe late-onset complications.

Purpose of the Study:

  • To investigate the spectrum and characteristics of post-COVID-19 complications and late COVID syndrome in children.
  • To identify common comorbidities and specific syndromes like MIS-C in pediatric patients following SARS-CoV-2 infection.

Main Methods:

  • Retrospective observational study of 60 children with post-COVID complications and late COVID syndrome at a tertiary pediatric clinic.
  • Analysis of clinical data, medical history, serological markers (including antibody tests, ANA, ANF), and patient outcomes.

Main Results:

  • Over half of the 60 children studied were under 5 years old; 85% were previously healthy.
  • Documented complications included vasculopathy, immune thrombocytopenia, anemia, coagulopathy, pneumonia, and exacerbation of underlying conditions.
  • Eight children (13%) presented with multisystem inflammatory syndrome in children (MIS-C), some exhibiting Kawasaki disease-like symptoms, with one developing a coronary artery aneurysm.

Conclusions:

  • Post-COVID-19 complications and late COVID syndrome can occur even after asymptomatic or mild SARS-CoV-2 infections in children.
  • Thorough examination and dynamic monitoring are crucial for pediatric patients following COVID-19 to detect and manage potential long-term sequelae.
  • The study highlights the importance of recognizing MIS-C and other inflammatory conditions in the pediatric post-COVID landscape.